EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dual-action selenium nanodrugs confer synergistic protection against Parkinson’s Disease via mitochondrial-targeted antioxidant therapy and selenoprotein p-mediated selenium mobilization

Li Lei, Lingli Song, Qihang Ao, Qian Zheng, Qiuxia Tu, Wen Zheng, Jiaojiao Wang, Xincheng Long, Yongsheng Huang, Shengkai Li, Haijun Yu, Lei Tang und 1 weitere

Advanced Composites and Hybrid Materials · 2026-06 · 9 (3)

DOI: 10.1007/s42114-026-01809-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Composites and Hybrid Materials, online erschienen am 25.04.2026. Verfasst von Li Lei und 12 weiteren Autor:innen. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lei, L., Song, L., Ao, Q., Zheng, Q., Tu, Q., Zheng, W., Wang, J., Long, X., Huang, Y., Li, S., Yu, H., Tang, L., & Zhang, C. (2026). Dual-action selenium nanodrugs confer synergistic protection against Parkinson’s Disease via mitochondrial-targeted antioxidant therapy and selenoprotein p-mediated selenium mobilization. Advanced Composites and Hybrid Materials, 9(3). https://doi.org/10.1007/s42114-026-01809-4

Vancouver

Lei L, Song L, Ao Q, Zheng Q, Tu Q, Zheng W, et al. Dual-action selenium nanodrugs confer synergistic protection against Parkinson’s Disease via mitochondrial-targeted antioxidant therapy and selenoprotein p-mediated selenium mobilization. Advanced Composites and Hybrid Materials. 2026;9(3). doi:10.1007/s42114-026-01809-4

BibTeX
@article{Lei2026,
  author = {Lei, Li and Song, Lingli and Ao, Qihang and Zheng, Qian and Tu, Qiuxia and Zheng, Wen and Wang, Jiaojiao and Long, Xincheng and Huang, Yongsheng and Li, Shengkai and Yu, Haijun and Tang, Lei and Zhang, Chunlin},
  title = {Dual-action selenium nanodrugs confer synergistic protection against Parkinson’s Disease via mitochondrial-targeted antioxidant therapy and selenoprotein p-mediated selenium mobilization},
  journal = {Advanced Composites and Hybrid Materials},
  year = {2026},
  volume = {9},
  number = {3},
  doi = {10.1007/s42114-026-01809-4}
}
Kostenlos starten →